Results 21 to 30 of about 3,018,020 (304)
Bacteriophage T4 Vaccine Platform for Next-generation Influenza Vaccine Development [PDF]
Abstract Developing influenza vaccines that protect against a broad range of viruses is a public health priority, and several conserved viral proteins or domains have been identified as promising targets for such vaccine development.
Mengling Li +21 more
openaire +4 more sources
Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination
Multiple factors, including vaccine platform and prior vaccinations, influence vaccine responses. We compared antibody responses to CoronaVac (Sinovac) and ChAdOx1-S (AstraZeneca-Oxford) vaccination in 874 healthcare workers in Brazil. As participants were randomised to BCG vaccination or placebo in the preceding 0-6 months as part of the BCG ...
Nicole L. Messina +25 more
openaire +4 more sources
Vaccine platform recombinant measles virus [PDF]
The classic development of vaccines is lengthy, tedious, and may not necessarily be successful as demonstrated by the case of HIV. This is especially a problem for emerging pathogens that are newly introduced into the human population and carry the inherent risk of pandemic spread in a naïve population.
openaire +2 more sources
VelcroVax: a “Bolt-On” Vaccine Platform for Glycoprotein Display
The hepatitis B core protein (HBc) forms noninfectious virus-like particles, which can be modified to present a capturing molecule, allowing suitably tagged antigens to be bound on their surface. This system can be adapted and provides the foundation for a universal “bolt-on” vaccine platform (termed VelcroVax) that can be easily and rapidly modified ...
Natalie J. Kingston +19 more
openaire +4 more sources
COVID-19 vaccine development pipeline
A COVID-19 vaccine development tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, that follows COVID-19 vaccine candidates as they progress through the development ...
Vaccine Centre
core +3 more sources
Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials. [PDF]
BACKGROUND: Phase III trials of the malaria vaccine, RTS, S, are now underway across multiple sites of varying transmission intensity in Africa. Heterogeneity in exposure, vaccine response and waning of efficacy may bias estimates of vaccine efficacy ...
Michael T White +11 more
core +1 more source
Platform technologies for modern vaccine manufacturing
Improved understanding of antigenic components and their interaction with the immune system, as supported by computational tools, permits a sophisticated approach to modern vaccine design. Vaccine platforms provide an effective tool by which strategically designed peptide and protein antigens are modularized to enhance their immunogenicity.
Charlton Hume, Hayley K. +1 more
openaire +5 more sources
[[abstract]]Since newly emerging influenza viruses with pandemic potentials occurred in recent years, the demand for producing pandemic influenza vaccines for human use is high. For the development of a quick and efficient vaccine production, we proposed
Tseng, YF;Weng, TC;Lai, CC;Chen, PL;Lee, MS;Hu, AYC
core +1 more source
Tuberculosis still claims more lives than any other pathogen, and a vaccine better than BCG is urgently needed. One of the challenges for novel TB vaccines is to protect against all Mycobacterium tuberculosis lineages, including the most virulent ones ...
권기웅, 신성재
core +1 more source
Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants
Attenuated SA14-14-2 Japanese encephalitis (JE) vaccine has been administered safely and effectively to more than 100 million children in China since 1988 and recently, licensure of the vaccine in Korea has been sought.
박민수
core +1 more source

